PreMarket Price
PreMarket Price
Exelon Corporation (EXC) logo

Stock Analysis

Exelon CorporationEXC

Price:$43.50Market Closed+2.40%at last close

P/E 16.10×· 5Y range 13.14–507.06×· 31th percentile of history

Sector: Utilities · Industry: Electric & Other Services Combined

AnalystsHold26 analysts
EW Score 29/65 · #380Mkt Cap 44.82BP/E 16.1Div Yield 3.81%ROE 9.4%
Low 13.1×16.1×High 507.1×

P/E 16.1× sits at the 31st percentile of its 5.0978781656399725-year history.

Cash $1.81BNet debt $50.86BDebt $52.67B

Cash covers 3% of debt · Q2 2026.

Profilev57g60p57h20q62m12

PMP Verdict

Mixed fundamentals, fairly valued

Strengths

  • Quality62
  • Growth60

Risks

  • Financial Health20
Revenue -9.6% CAGRP/E 16× · 31st pctl

Mixed picture — no clear quality or value edge.

Market context

+2.4% today· Z 2.5σ· EXC rose 2.47% amid surging interest in utility stocks riding the AI data center power boom.

Bull Case

  • ✓Piotroski F-Score 7/9 — high earnings quality

Why is EXC moving?

Sector

EXC rose 2.47% amid surging interest in utility stocks riding the AI data center power boom.

AI confidence:High (85%)·+2.40% today

Profile

Valuation — 57/100 (Moderate) P/E vs own history: 31th pct → 20/25 FCF yield: -4.3% → 0/25 P/S: 1.8x → 25/25 EV/EBIT: 18.2x → 12/25Valuation57Growth — 60/100 (Moderate) Revenue CAGR: -9.6% → 0/25 Net income CAGR: 12.9% → 20/25 EPS CAGR 5Y: 12.0% → 20/25 Fwd implied growth: 15.2% → 20/25Growth60Profitability — 57/100 (Moderate) ROIC: 5.2% → 5/25 ROE: 9.4% → 12/25 Net margin: 11.0% → 20/25 Operating margin: 20.8% → 20/25Profitability57Financial Health — 20/100 (Weak) Altman Z: 0.58 → 3/25 Current ratio: 1.09 → 12/25 Interest coverage: -0.3x → 0/25 Net cash / debt: D/A 42% → 5/25Health20Quality — 62/100 (Moderate) Piotroski F: 7/9 → 22/25 Beneish M: -2.43 → 20/25 FCF conversion: -69% → 0/25 Margin stability: σ 5.5% → 20/25Quality62Moat — 12/100 (Weak) ROIC >12% years: 0/10 yrs → 0/25 Median gross margin: 12.0% → 0/25 FCF-positive years: 1/10 yrs → 0/25 Worst-year net margin: worst 3.6% → 12/25Moat12

moat and financial health lag behind.

How is each axis scored?
  • Valuation57/100 · Moderate
    • P/E vs own history (31th pct)20/25
    • FCF yield (-4.3%)0/25
    • P/S (1.8x)25/25
    • EV/EBIT (18.2x)12/25
  • Growth60/100 · Moderate
    • Revenue CAGR (-9.6%)0/25
    • Net income CAGR (12.9%)20/25
    • EPS CAGR 5Y (12.0%)20/25
    • Fwd implied growth (15.2%)20/25
  • Profitability57/100 · Moderate
    • ROIC (5.2%)5/25
    • ROE (9.4%)12/25
    • Net margin (11.0%)20/25
    • Operating margin (20.8%)20/25
  • Financial Health20/100 · Weak
    • Altman Z (0.58)3/25
    • Current ratio (1.09)12/25
    • Interest coverage (-0.3x)0/25
    • Net cash / debt (D/A 42%)5/25
  • Quality62/100 · Moderate
    • Piotroski F (7/9)22/25
    • Beneish M (-2.43)20/25
    • FCF conversion (-69%)0/25
    • Margin stability (σ 5.5%)20/25
  • Moat12/100 · Weak
    • ROIC >12% years (0/10 yrs)0/25
    • Median gross margin (12.0%)0/25
    • FCF-positive years (1/10 yrs)0/25
    • Worst-year net margin (worst 3.6%)12/25

Risk Flags

  • ⚠Altman Z 0.6 — distress-zone balance sheet
  • ⚠Negative FCF margin (-0.1%) — burning cash
  • ⚠Interest coverage -0.3× — thin debt cushion
  • ⚠Revenue shrinking 9.6%/yr

About Exelon Corporation

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D. Show more

C.

Headquarters: CHICAGO, IL · Employees: 20,571 · Website ↗

Price History

Weekly Candlestick Chart — up to 5Y

Key Metrics

Financial snapshot · Tap any metric for its definition and grade

TTM Snapshot

trailing twelve months · YoY
Revenue
25.3B+7%
Op. Income
5.3B+22%
Net Income
2.8B+5%
EPS
2.71+3%
Operating CF
7.2B+24%
Free CF
-1.9B

Valuation

57C
P/E (TTM)16.1xB

Grade B: FairPrice / TTM EPS (own statements) — vs own 5Y history: 13.1x–507.1x · 31st pct

P/FCF268.9xD

Grade D: ExpensivePrice / Free Cash Flow per share (Finnhub). Inverse of FCF yield — negative when FCF is negative · CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

FCF Yield-4.3%D

Grade D: NegativeTTM (OCF − CapEx) / Market Cap — vs own 5Y history: -11.9%–-3.1% · 62nd pct · CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

P/S (TTM)1.77xA

Grade A: CheapPrice / TTM Revenue (own statements) — vs own 5Y history: 1.2x–2.2x · 51st pct

EV/EBIT18.2xC

Grade C: ExpensiveEnterprise value / TTM EBIT (D&A not in our data) — capital-structure neutral — vs own 5Y history: 17.7x–66.3x · 6th pct

EV/Sales3.7xB

Grade B: FairEnterprise Value / TTM Revenue (Finnhub) — capital-structure neutral sales multiple

Forward P/E14.0xA

Grade A: CheapPrice / next-year EPS estimate — shows whether the TTM multiple is rich or just front-loading growth

P/B Ratio1.51xA

Grade A: FairPrice to Book Value. Neg. equity = heavy buybacks

PEG Ratio1.65B

Grade B: FairFinnhub PEG — their P/E basis ÷ expected EPS growth. Suppressed when their P/E diverges >2× from our TTM P/E (different basis)

Dividend Yield3.81%A

Grade A: PaysTTM dividend yield (Finnhub) — annual dividends / price. None = no dividend; very high yield can signal distress

Payout Ratio60.0%A

Grade A: SafeDividends / Net Income (Finnhub) — share of earnings paid out; >90% or negative = unsustainable

P/E vs own 5Y historyBelow average · 31st pct

CapEx exceeds OCF: CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

Profitability

57C
ROIC5.2%D

Grade D: LowNOPAT (EBIT less ~21% tax) / invested capital (equity + debt − cash). Flagship quality metric — durable >15% signals a moat

ROE9.4%D

Grade D: WeakReturn on Equity. Neg. equity = heavy buybacks

ROA2.4%D

Grade D: WeakReturn on Assets (Finnhub) — Net Income / Total Assets; how efficiently assets produce profit

Net Margin11.0%A

Grade A: HighNet Income / Revenue

Operating Margin20.8%C

Grade C: AverageTTM EBIT / TTM Revenue

Gross Margin20.8%D

Grade D: LowGross Profit / Revenue

FCF Margin-7.6%D

Grade D: LowFCF / Revenue · CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

True FCF Margin-7.6%D

Grade D: LowTTM (OCF − CapEx − SBC) / TTM Revenue — SBC treated as a real cost · CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

Growth

60B
Revenue CAGR-9.6%D

Grade D: LowCompound annual revenue growth (up to 5Y depending on data availability)

Net Income CAGR12.9%C

Grade C: OkCompound annual net income growth (up to 5Y depending on data availability)

EPS CAGR (5Y)12.0%C

Grade C: OkCompound annual EPS growth over up to 5Y of per-share earnings (own statements). Null when either endpoint EPS ≤ 0

Implied EPS Growth15.2%C

Grade C: MedAnalyst forward EPS (normalized basis) vs our GAAP TTM EPS — different bases, so extreme values usually mark cyclically depressed TTM earnings, not real growth

Dilution (5Y)+5.2%C

Grade C: DilutiveShare count change over 5Y

SBC / Net Income—

Stock-based comp/Net income. >30% = dilution risk

SBC / Revenue—

TTM stock-based comp / TTM Revenue

Financial Health

20E
Altman Z-Score0.58D

Grade D: DistressBankruptcy risk. >3 Safe, <1.8 Distress

Current Ratio1.09xC

Grade C: OkCurrent Assets/Liabilities

Quick Ratio0.95xC

Grade C: Ok(Current Assets − Inventory) / Current Liabilities (Finnhub) — stricter liquidity test, excludes inventory

Interest Coverage-0.3xD

Grade D: RiskyEBIT/Interest. >10 Strong

Debt Repayment—

Years to repay net debt via FCF · CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

Net Debt/EBIT9.7xD

Grade D: HighLeverage. <2x Low, >4x High

Debt/Equity1.77xC

Grade C: MedDebt / Equity: <1 Conservative, >2 Risky. Not meaningful with non-positive equity; shown as unavailable rather than low debt.

Cash / Debt0.03xD

Grade D: ThinCash covers how much of total debt. >1 = could repay all debt from cash

Quality

62B
Piotroski F-Score7/9A

Grade A: StrongFinancial strength 0–9. >7 Strong

Beneish M-Score-2.43A

Grade A: SafeEarnings manipulation risk. < -2.22 Safe

FCF Conversion-68.8%D

Grade D: PoorFCF / Net Income · CapEx exceeds operating cash flow (127% of OCF) — reported FCF understates normalized earning power in this investment phase

Margin Stability5.5%A

Grade A: StableEBIT margin std deviation. Lower = stable

Capex / Revenue36.0%D

Grade D: HeavyTTM CapEx / TTM Revenue — high % = capital-hungry business

Asset Turnover0.22xD

Grade D: LowRevenue / Total Assets (Finnhub) — how efficiently the asset base generates sales

Insider Transactions

SEC Form 4 · 8 records
Open-market · 90dBuy —Sell —Other filings 4No open-market trades

P/S codes are the directional signal; grants, option exercises and tax withholding carry none. Form 4 doesn't flag 10b5-1 plans — scheduled sales may appear within open-market sells.

Recent insider transactions
Trade dateTransactionShares
Rogers Matthew C
Filed
Grant / award
+897
Lillie Charisse R
Filed
Grant / award
+6
Cheshire Marjorie Rodgers
Filed
Grant / award
+511
BOWERS WILLIAM P
Filed
Grant / award
+1.1K
Rogers Matthew C
Filed
Grant / award
+778
Show 3 more filings
Additional recent insider transactions
Trade dateTransactionShares
Lillie Charisse R
Filed
Grant / award
+5
Cheshire Marjorie Rodgers
Filed
Grant / award
+442
BOWERS WILLIAM P
Filed
Grant / award
+925
More metrics — Moat, Per Share, Balance Sheet, Market

Moat

12E
ROIC >12% Years0/10 yrsD

Grade D: WeakShare of completed fiscal years with ROIC > 12% — measures multi-year capital-return durability

Gross Margin (Med.)12.0%D

Grade D: WeakMedian annual gross margin across available fiscal years — pricing-power durability

FCF-Positive Years1/10 yrsD

Grade D: WeakShare of completed fiscal years with positive free cash flow

Net Margin Floor3.6%C

Grade C: ModerateWeakest annual net margin across completed fiscal years — recession/downcycle resilience

Per Share

EPS (TTM)$2.70

Own TTM net income / shares — same earnings basis as P/E

Cash / Share$1.76

Cash & short-term investments per share (Finnhub)

Book Value / Share$28.78

Shareholders' equity per share (Finnhub). Negative = accumulated losses / heavy buybacks

Balance Sheet

Total Debt$52.67B

Total debt obligations (short + long term)

Cash & Equiv.$1.81B

Cash and short-term investments

Net Debt$50.86B

Total Debt minus Cash. Negative = Net Cash position

Total Equity$29.70B

Shareholders' equity (book value)

Asset / Liability1.33xC

Grade C: AdequateTotal Assets / Total Liabilities

Market

Market Cap$44.82B

Current Market Capitalization

Beta0.26B

Grade B: DefensivePrice sensitivity vs the market (Finnhub) — 1.0 moves with market, >1.2 amplifies swings

How grades work: each metric is graded A–D against fixed thresholds (tap a row for the meaning). Card grades map the pillar score to A+–E — a card grade is that pillar's own score, not an average of the rows shown.

Financials as of Jun 2026 · Ratio snapshot Oct 17, 2026

Key Insights: Exelon Corporation (EXC)

EXC is up 2.40% at the last close — EXC rose 2.47% amid surging interest in utility stocks riding the AI data center power boom.. Exelon Corporation meets 7 of 9 Piotroski F-Score criteria, placing its fundamental strength in the top tier of US-listed stocks. Altman Z-Score of 0.58 is below the 1.81 distress threshold — an elevated financial-risk flag. Beneish M-Score of -2.43 suggests a low likelihood of earnings manipulation. Revenue has been contracting (CAGR ≈ -10%), which weighs on the growth outlook.

  • Free-cash-flow margin is negative (-8%) — the business currently burns cash.
  • Company has negative FCF, making debt repayment from operations difficult.
  • Interest coverage of -0.3× leaves little room for earnings shocks.
  • The stock currently yields 3.8% in dividends.

See how EXC ranks on the Capex Tracker — top 50 capital spenders compared.

Recent Market Moves

See all EXC moves →
DateSessionPriceMoveZ-Score
Oct 16Regular43.49+2.37%2.43
Oct 16After-hours43.50+2.40%2.46
Oct 6Regular41.45+1.54%2.27
Oct 6After-hours42.01+2.92%3.85
Sep 23Regular40.71-2.62%-2.93

Frequently Asked Questions about EXC

What is the current Exelon Corporation (EXC) stock price?

EXC is trading at $43.50 at the last market close, up 2.40% on the session. PreMarketPrice tracks EXC pre-market, intraday and after-hours prices.

Is EXC stock a buy right now?

PreMarketPrice's quantitative model rates Exelon Corporation's financial health at 20/100. This is a data-driven snapshot of fundamentals, not investment advice.

Is EXC stock overvalued?

Exelon Corporation trades at a trailing P/E of 16.1 and our valuation score rates it 57/100 (higher = cheaper vs. its own history). See the Valuation History and Key Metrics sections for forward P/E, EV/EBITDA and PEG context.

When does Exelon Corporation report earnings?

No confirmed earnings date is currently scheduled for EXC. The Earnings section lists recent reports and updates as dates are announced.

What sector does Exelon Corporation operate in?

Exelon Corporation operates in the Utilities sector, within the Electric & Other Services Combined industry. The Related Stocks section lists sector peers for comparison.

What does Exelon Corporation do?

Exelon serves approximately 10 million power and gas customers at its six regulated utilities in Illinois, Pennsylvania, Maryland, New Jersey, Delaware, and Washington, D.

About Exelon Corporation (EXC) Stock

Exelon Corporation (EXC) is a US-listed stock operating in the Utilities sector, specifically the Electric & Other Services Combined industry. As of the latest update, Exelon Corporation is trading at $43.50, up 2.40% on the day with a market capitalization of $44.8 billion. The financial health score for EXC is 20/100, which indicates poor financial strength based on profitability, leverage, liquidity, and growth metrics. This page provides real-time pre-market pricing, earnings calendar, financial health analysis, and valuation metrics for EXC stock.

EXC Stock Analysis & Key Metrics

On PreMarketPrice, you can track Exelon Corporation (EXC) across multiple dimensions:

Is EXC a Good Stock to Buy?

This page provides data-driven analysis to help you evaluate Exelon Corporation (EXC) as an investment. The financial health score of 20/100 suggests poor financial fundamentals. Valuation metrics show whether the stock is trading above or below its historical average.However, this is not financial advice — always do your own research before investing.

Data on this page is sourced from real-time market feeds, Polygon.io, and Finnhub.Exelon Corporation (EXC) trades on NYSE/NASDAQ. Pre-market trading occurs 4:00 AM – 9:30 AM ET. Regular market hours are 9:30 AM – 4:00 PM ET.

Related opportunities

Moving today in Utilities
More Electric & Other Services Combined stocks
Cheaper alternatives
Similar fundamentals